 SAN DIEGO, Oct. 29, 2020 PRNewswire -- Biocept, Inc. Nasdaq: BIOC, a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer, announces an update on its COVID-19 testing with more than 80,000 samples received to date for... 